Binnopharm Group pharmaceuticals demonstrate consistently high dynamics of pharmacy sales – the company ranked 4th among the market leaders in September 2023

According to the analytical report of AlphaRM for September 2023, Binnopharm Group ranked 4th among the leaders of the Russian pharmacy sales market (sell out), becoming the 2nd among Russian pharmaceutical corporations. The volume of Binnopharm Group pharmaceuticals sales by value for the period amounted to RUB 3.87 billion. During the year the company has been confidently demonstrating stable growth in the retail market, having twice shown impressive dynamics in pharmacy sales of pharmaceuticals − in July, taking the 7th place, and in September – the 4th place.

 
Rustem Muratov, CEO of Binnopharm Group: «Our products once again confirm high results and customer loyalty, which proves the correctness of the business model that we chose. Binnopharm Group is ahead of the market despite external challenges. This is our team’s merit, the result of invested efforts in our production sites modernization, and portfolio development».